Dublin, April 26, 2019 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cells (CTC) Market Size, Share & Trends Analysis Report By By Technology (Detection, Enrichment), Application (Cancer Stem Cell Research, EMT Biomarkers Development), And Segment Forecasts, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.
The global circulating tumor cells market size is anticipated to reach USD 17.56 billion by 2025 growing at a CAGR of 15% during the forecast period.
Introduction of novel technologies for enumeration of CTC is anticipated to fuel the market growth. Rising cases of chronic oncology diseases that depend on CTC detection and analysis, as it has enormous potential in real-time monitoring of cancer therapy over methods like imaging technologies and tumor tissue biopsy, will also drive the market.
Additionally, application of CTC as biomarkers for drug discovery is a promising factor for growth in the coming years. Utilization of the CTCs in the development of tumor-specific biomarkers to optimize the selection of targeted therapies and assessment of better response to the therapy is expected to support in the market growth. CTC enrichment accounted for the largest revenue share of the global market in 2018 and is expected to continue the dominance throughout the forecast period. This is due to extensive usage in oncology research establishments and high accuracy exhibited by this technology.
Microchips technology is anticipated to register the highest CAGR owing to the introduction of cluster chip technology that helps capture the clusters of tumor cells for CTC quantitation. Cancer stem cell research segment accounts for the largest revenue share of the market. Properties of the cancer stem cells of self-renewal in replenishing the growing cancer is driving the attention of organizations and researchers in CTC cancer stem cell research segment.
Further key findings from the study suggest:
- Application of alterations in the expression profiles of EMT-associated transcriptional regulators and their molecular targets as biomarkers in EMT study is expected to serve as an impetus for diagnosis of tumor
- North America led the CTC market in 2018 due to rising cases of cancer, oncology research funding, and favorable government initiatives for clinical diagnostic products
- APAC is anticipated to witness the highest CAGR of over 16% from 2019 to 2025 due to infrastructural development in care centers and increased sales of CTC diagnostic tests
- Rising need for new diagnosis methods for cancer has encouraged R&D in developing economies of APAC. This will help expand the region further
- Fluxion Biosciences, Inc.; AdnaGen AG; Biocept, Inc.; Ikonisys, Inc.; and Sysmex Corp. are some of the key industry participants
- Key companies focus on the development of novel technologies for CTC enrichment & detection through collaborations with hospitals and university-based research institutes to gain access to target population
Key Topics Covered
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources & third party perspectives
1.3.4. Primary research
1.4. Information Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. CTC Market Outlook, 2014 - 2025
2.2. CTC Market Segment Outlook, 2014 - 2025
2.3. Competitive Insights
Chapter 3. CTC Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. User Perspective Analysis
3.4.1. Consumer behavior analysis
3.4.2. Market influencer analysis
3.4.3. Procedure cost analysis/breakdown
3.5. Technology Overview
3.5.1. Technology timeline
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & compliances
3.7. Market Dynamics
3.7.1. Market driver analysis
3.7.2. Market restraint analysis
3.7.3. Industry challenges
3.8. CTC Market Analysis Tools
3.8.1. Industry analysis - Porter's
3.8.2. PESTEL Analysis
3.8.3. Major Deals & Strategic Alliances Analysis
3.8.4. Market entry strategies
3.8.5. Case studies
Chapter 4. CTC Market - Competitive Analysis
4.1. Recent Developments & Impact Analysis, by Key Market Participants
4.2. Company/Competition Categorization
4.3. Vendor Landscape
4.3.1. List of key distributors and channel partners
4.3.2. Key customers
4.3.3. Key company market share analysis, 2018
4.4. Public Companies
4.4.1. Company market position analysis
4.4.2. Company market share/ranking, by region
4.4.3. Competitive dashboard analysis
4.4.4. Market differentiators
4.4.5. Synergy analysis: major deals & strategic alliances
4.5. Private Companies
4.5.1. List of key emerging companies' products
4.5.2. Regional network map
4.5.3. Company market position analysis
4.5.4. Supplier ranking
Chapter 5. CTC Market: Technology Estimates & Trend Analysis
5.1. Definitions & Scope
5.2. Technology Market Share Analysis, 2018 & 2025
5.3. Segment Dashboard
5.4. Global CTC Market, by Technology, 2014 to 2025
5.5. Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following:
5.5.1. CTC enrichment methods market, 2014 to 2025
5.5.2. CTC detection methods market, 2014 to 2025
5.5.3. CTC analysis market, 2014 to 2025
5.6. CTC Technology Market, by Application, 2014 to 2025
5.6.1. Market revenue (USD Million), 2014 to 2025
Chapter 6. CTC Market: Application Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. Application Market Share Analysis, 2018 & 2025
6.3. Segment Dashboard
6.4. Global CTC Market, by Application, 2014 to 2025
6.5. Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following:
6.5.1. Cancer stem cell research market, 2014 to 2025
6.5.2. EMT biomarkers development market, 2014 to 2025
6.5.3. Tumorgenesis research market, 2014 to 2025
6.5.4. Other applications market, 2014 to 2025
Chapter 7. CTC Market: Regional Estimates & Trend Analysis, by Technology and Application
7.1. CTC Market: Regional Snapshot
7.2. CTC Market: Regional Share and Leading Players, 2018
7.3. North America
7.4. Europe
7.5. Asia Pacific
7.6. Latin America
7.7. Middle East & Africa (MEA)
7.8. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
Chapter 8. Company Profiles
8.1. Company Profiles
8.1.1. Adnagen AG
8.1.2. Advanced Cell Diagnostics
8.1.3. Apocell
8.1.4. Aviva Biosciences
8.1.5. Biocep Ltd.
8.1.6. Biocept Inc.
8.1.7. Biofluidica
8.1.8. Canopus Biosciences
8.1.9. CellTraffix Inc.
8.1.10. Clearbridge BioMedics
8.1.11. Creatv Microtech Inc.
8.1.12. Cynvenio Biosystems Inc.
8.1.13. Epic Biosciences
8.1.14. Fluxion Biosciences
8.1.15. Greiner Bio-One GmbH
8.1.16. Ikonisys Inc.
8.1.17. IV Diagnostics Inc.
8.1.18. Janssen Diagnostics
8.1.19. Miltenyi Biotech
8.1.20. Nanostring Technologies Inc.
8.1.21. Rarecells
8.1.22. ScreenCell
8.1.23. Silicon Biosystems USA
8.1.24. Stem Cell Technologies
8.1.25. Sysmex Corporation
8.1.26. Vitatex Inc
8.2. List of companies
For more information about this report visit https://www.researchandmarkets.com/r/kk4gxi
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.